BIOMAT Database Logo BIOMAT Database Logo

Potent and Selective Inhibitors of Human Sirtuin 5. 2018

Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Department of Enzymology, Institute of Biochemistry and Biotechnology , Martin-Luther-University Halle-Wittenberg , 06120 Halle/Saale , Germany.

Sirtuins are protein deacylases that regulate metabolism and stress responses and are implicated in aging-related diseases. Modulators of the human sirtuins Sirt1-7 are sought as chemical tools and potential therapeutics, e.g., for cancer. Selective and potent inhibitors are available for Sirt2, but selective inhibitors for Sirt5 with Ki values in the low nanomolar range are lacking. We synthesized and screened 3-arylthiosuccinylated and 3-benzylthiosuccinylated peptide derivatives yielding Sirt5 inhibitors with low-nanomolar Ki values. A biotinylated derivative with this scaffold represents an affinity probe for human Sirt5 that is able to selectively extract this enzyme out of complex biological samples like cell lysates. Crystal structures of Sirt5/inhibitor complexes reveal that the compounds bind in an unexpected manner to the active site of Sirt5.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D019295 Computational Biology A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories for solving biological problems including manipulation of models and datasets. Bioinformatics,Molecular Biology, Computational,Bio-Informatics,Biology, Computational,Computational Molecular Biology,Bio Informatics,Bio-Informatic,Bioinformatic,Biologies, Computational Molecular,Biology, Computational Molecular,Computational Molecular Biologies,Molecular Biologies, Computational
D020349 Surface Plasmon Resonance A biosensing technique in which biomolecules capable of binding to specific analytes or ligands are first immobilized on one side of a metallic film. Light is then focused on the opposite side of the film to excite the surface plasmons, that is, the oscillations of free electrons propagating along the film's surface. The refractive index of light reflecting off this surface is measured. When the immobilized biomolecules are bound by their ligands, an alteration in surface plasmons on the opposite side of the film is created which is directly proportional to the change in bound, or adsorbed, mass. Binding is measured by changes in the refractive index. The technique is used to study biomolecular interactions, such as antigen-antibody binding. Plasmon Resonance, Surface,Plasmon Resonances, Surface,Resonance, Surface Plasmon,Resonances, Surface Plasmon,Surface Plasmon Resonances

Related Publications

Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.
October 2014, Journal of medicinal chemistry,
Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Structure-based discovery of new selective small-molecule sirtuin 5 inhibitors.
January 2018, Chemical biology & drug design,
Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Potent and selective xanthine-based inhibitors of phosphodiesterase 5.
April 2007, Bioorganic & medicinal chemistry letters,
Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Discovery of Dihydro-1,4-Benzoxazine Carboxamides as Potent and Highly Selective Inhibitors of Sirtuin-1.
May 2021, Journal of medicinal chemistry,
Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
5-amino-pyrazoles as potent and selective p38α inhibitors.
December 2010, Bioorganic & medicinal chemistry letters,
Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Potent and selective 5-lipoxygenase inhibitors: cirsiliol and AA-861.
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.
July 2017, European journal of medicinal chemistry,
Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Enzymatic Studies of Isoflavonoids as Selective and Potent Inhibitors of Human Leukocyte 5-Lipo-Oxygenase.
July 2015, Chemical biology & drug design,
Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Novel xanthone derivatives as potent sirtuin 2 inhibitors.
January 2024, Bioorganic & medicinal chemistry letters,
Diana Kalbas, and Sandra Liebscher, and Theresa Nowak, and Marat Meleshin, and Martin Pannek, and Corinna Popp, and Zayan Alhalabi, and Frank Bordusa, and Wolfgang Sippl, and Clemens Steegborn, and Mike Schutkowski
Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication.
June 1999, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!